Stay updated on market trends for CAPR. Jabil Posts Better-Than-Expected Earnings, Joins Darden Restaurants, QXO, Five Below And Other Big Stocks Moving Higher On Thursday Avi Kapoor Capricor ...

Our analysis of options history for Capricor Therapeutics CAPR revealed 8 unusual trades. Delving into the details, we found 25% of traders were bullish, while 62% showed bearish tendencies.

SAN DIEGO, March 07, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare ...

CAPR has been the subject of a number of analyst reports. HC Wainwright reaffirmed a “buy” rating and issued a $77.00 price target on shares of Capricor Therapeutics in a report on Thursday ...

CAPRICOR THERAPEUTICS ($CAPR) posted quarterly earnings results on Wednesday, March 19th. The company reported earnings of -$0.16 per share, beating estimates of -$0. ...

Capricor Therapeutics (CAPR) released expectation-beating results for the fourth quarter, sending the shares up over 5% in aftermarket trading. This comes on the heels of the company achieving a ...